Cassian Yee

Cassian Yee

UNVERIFIED PROFILE

Are you Cassian Yee?   Register this Author

Register author
Cassian Yee

Cassian Yee

Publications by authors named "Cassian Yee"

Are you Cassian Yee?   Register this Author

81Publications

1945Reads

44Profile Views

CTL-mediated immunotherapy can suppress SHIV rebound in ART-free macaques.

Nat Commun 2019 05 21;10(1):2257. Epub 2019 May 21.

Department of Microbiology & Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41467-019-09725-6
Publisher Site
http://dx.doi.org/10.1038/s41467-019-09725-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529452PMC
May 2019

Hydrodynamic shear stress promotes epithelial-mesenchymal transition by downregulating ERK and GSK3β activities.

Breast Cancer Res 2019 01 16;21(1). Epub 2019 Jan 16.

Department of Stem Cell & Regenerative Biotechnology and Incurable Disease Animal Model and Stem Cell Institute (IDASI), Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, Republic of Korea.

View Article

Download full-text PDF

Source
https://breast-cancer-research.biomedcentral.com/articles/10
Publisher Site
http://dx.doi.org/10.1186/s13058-018-1071-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335853PMC
January 2019

An Update on Adoptive T-Cell Therapy and Neoantigen Vaccines.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:e70-e78. Epub 2019 May 17.

4 Center for Cancer Research, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_238001DOI Listing
January 2019

From the Guest Editor.

Authors:
Cassian Yee

Cancer J 2017 Mar/Apr;23(2):95-96

From The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000256DOI Listing
October 2018

ImmTAC/Anti-PD-1 antibody combination to enhance killing of cancer cells by reversing regulatory T-cell-mediated immunosuppression.

Immunology 2018 10 14;155(2):238-250. Epub 2018 Jun 14.

State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, China.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/imm.12954
Publisher Site
http://dx.doi.org/10.1111/imm.12954DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142295PMC
October 2018

Early Env-specific CTLs effectively suppress viral replication in SHIV controller macaques.

Cell Immunol 2018 09 5;331:30-37. Epub 2018 May 5.

Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Haidian District, Beijing 100191, China; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Changping District, Beijing 102206, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellimm.2018.05.001DOI Listing
September 2018

Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer.

J Control Release 2018 09 3;285:23-34. Epub 2018 Jul 3.

Department of Nanomedicine, Houston Methodist Research Institute (HMRI), Houston, TX, USA; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, USA; Department of Surgery, Houston Methodist Hospital, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2018.06.035DOI Listing
September 2018

Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis.

Cancer Res 2018 05 6;78(10):2638-2653. Epub 2018 Feb 6.

Laboratory of Tumor Immunology, Department of Biomedical Sciences, Graduate School of Medicine, Korea University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-2325DOI Listing
May 2018

Adoptive T cell therapy: points to consider.

Authors:
Cassian Yee

Curr Opin Immunol 2018 04 2;51:197-203. Epub 2018 May 2.

Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, UT MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2018.04.007DOI Listing
April 2018

HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells.

Cancer Res 2017 09 17;77(18):5039-5053. Epub 2017 Jul 17.

Laboratory of Tumor Immunology, Department of Biomedical Sciences, Graduate School of Medicine, Korea University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-0072DOI Listing
September 2017

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes.

Clin Sarcoma Res 2017 15;7:11. Epub 2017 Jun 15.

Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13569-017-0077-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471883PMC
June 2017

Personalized Therapy: Tumor Antigen Discovery for Adoptive Cellular Therapy.

Cancer J 2017 Mar/Apr;23(2):144-148

From The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000255DOI Listing
May 2017

T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression.

J Clin Oncol 2016 11;34(31):3787-3795

Aude G. Chapuis, Ilana M. Roberts, Sylvia M. Lee, Heather L. Sloan, Ivy P. Lai, Erik A. Farrar, Felecia Wagener, Kendall C. Shibuya, Jianhong Cao, Philip D. Greenberg, and Cassian Yee, Fred Hutchinson Cancer Research Center; John A. Thompson, Kim A. Margolin, and Shailender Bhatia, Seattle Cancer Care Alliance and University of Washington, Seattle WA; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.5142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477923PMC
November 2016

Endogenous T-Cell Therapy: Clinical Experience.

Cancer J 2015 Nov-Dec;21(6):492-500

From the *Division of Cancer Medicine, Department of Melanoma Medical Oncology, †The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/journalppo/2015/11000/Endogenou
Web Search
http://dx.doi.org/10.1097/PPO.0000000000000158DOI Listing
September 2016

Interleukin-21 administration leads to enhanced antigen-specific T cell responses and natural killer cells in HIV-1 vaccinated mice.

Cell Immunol 2016 05 1;303:55-65. Epub 2016 Apr 1.

State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Changping District, Beijing 102206, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellimm.2016.03.006DOI Listing
May 2016

Homotypic NK cell-to-cell communication controls cytokine responsiveness of innate immune NK cells.

Sci Rep 2014 Dec 5;4:7157. Epub 2014 Dec 5.

1] Global Research Lab, Department of Biochemistry and Molecular Biology, Korea University College of Medicine, Seoul 136-713, Korea [2] Departments of Melanoma Medical Oncology and Immunology, MD Anderson Cancer Center Houston, TX 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep07157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256668PMC
December 2014

Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells.

J Immunother Cancer 2014 14;2(1):36. Epub 2014 Oct 14.

Clinical Research Division, D3-100 Fred Hutchinson Cancer Research Center, 1100 Fairview Ave, Seattle, WA 98109 USA ; Department of Medicine, University of Washington, Seattle, WA USA ; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, 7455 Fannin St, Unit 904, Houston, TX 77054 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-014-0036-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196009PMC
October 2014

API5 confers tumoral immune escape through FGF2-dependent cell survival pathway.

Cancer Res 2014 Jul 25;74(13):3556-66. Epub 2014 Apr 25.

Authors' Affiliations: Laboratory of Infection and Immunology, Graduate School of Medicine, Korea University; Global Research Lab, Division of Brain Korea 21 Program for Biomedical Science and Department of Biochemistry, Korea University College of Medicine, Seoul;

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/early/2014/04/25/0
Web Search
http://cancerres.aacrjournals.org/content/early/2014/06/12/0
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-13-3225DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394897PMC
July 2014

NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice.

Eur J Immunol 2014 Jun 16;44(6):1802-13. Epub 2014 Apr 16.

Global Research Laboratory, Department of Biochemistry and Molecular Biology, Korea University College of Medicine, Seoul, Republic of Korea; School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201343724DOI Listing
June 2014

Dissolution chemistry and biocompatibility of single-crystalline silicon nanomembranes and associated materials for transient electronics.

ACS Nano 2014 Jun 9;8(6):5843-51. Epub 2014 Apr 9.

Department of Materials Science and Engineering, Frederick Seitz Materials Research Laboratory, University of Illinois at Urbana-Champaign , Urbana, Illinois 61801, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/nn500847gDOI Listing
June 2014

Immunologic and tissue biocompatibility of flexible/stretchable electronics and optoelectronics.

Adv Healthc Mater 2014 Apr 1;3(4):515-25. Epub 2013 Sep 1.

Global Research Laboratory, Department of Biochemistry and Molecular Biology, Korea University College of Medicine, Seoul, 136-713, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/adhm.201300220DOI Listing
April 2014

The use of endogenous T cells for adoptive transfer.

Authors:
Cassian Yee

Immunol Rev 2014 Jan;257(1):250-63

Department of Melanoma Medical Oncology and Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imr.12134DOI Listing
January 2014

The effect of radiation on the immune response to cancers.

Int J Mol Sci 2014 Jan 10;15(1):927-43. Epub 2014 Jan 10.

Global Research Laboratory, Department of Biochemistry and Molecular Biology, Korea University College of Medicine, 126-1 Anam-dong 5-ga, Seongbuk-gu, Seoul 136-713, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms15010927DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907847PMC
January 2014

Adoptive T-cell therapy for cancer: boutique therapy or treatment modality?

Authors:
Cassian Yee

Clin Cancer Res 2013 Sep 6;19(17):4550-2. Epub 2013 Aug 6.

Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1367DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830944PMC
September 2013

HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway.

J Immunol 2013 Aug 12;191(4):1567-77. Epub 2013 Jul 12.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1300080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732835PMC
August 2013

Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy.

Cancer Res 2013 Apr 11;73(8):2598-607. Epub 2013 Apr 11.

Global Research Laboratory, Department of Biochemistry and Molecular Biology, Korea University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-2893DOI Listing
April 2013

Single step isolation and activation of primary CD3+ T lymphocytes using alcohol-dispersed electrospun magnetic nanofibers.

Nano Lett 2012 Aug 26;12(8):4018-24. Epub 2012 Jul 26.

Global Research Lab, Department of Biochemistry and Molecular Biology, Korea University College of Medicine, Seoul 136-713, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/nl301388dDOI Listing
August 2012

Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer.

J Immunother 2012 Feb-Mar;35(2):131-41

Program in Immunology, Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e31824300c7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288118PMC
May 2012

Another LAP in the race.

Cancer Discov 2012 Feb;2(2):107-9

Clinical Research Division, Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-12-0010DOI Listing
February 2012

Immune-based therapies for sarcoma.

Sarcoma 2011 23;2011:438940. Epub 2011 Jan 23.

Fred Hutchinson Cancer Research Center, University of Washington, 825 Eastlake Avenue East, G3630, Seattle, WA 98109-1023, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/438940DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034923PMC
July 2011

White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy.

Clin Cancer Res 2011 Apr 15;17(7):1664-73. Epub 2011 Feb 15.

Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2272DOI Listing
April 2011

Adoptive therapy using antigen-specific T-cell clones.

Authors:
Cassian Yee

Cancer J 2010 Jul-Aug;16(4):367-73

Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Division of Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00130404-201007000-000
Publisher Site
http://dx.doi.org/10.1097/PPO.0b013e3181eacba8DOI Listing
December 2010

Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses.

J Immunol 2010 Jun 7;184(11):6514-21. Epub 2010 May 7.

Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0900448DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313650PMC
June 2010

CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumors.

J Invest Dermatol 2008 Dec 19;128(12):2870-9. Epub 2008 Jun 19.

Department of Pharmacology, University of Washington, Seattle, Washington 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2008.170DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135173PMC
December 2008

A multimodal targeting nanoparticle for selectively labeling T cells.

Small 2008 Jun;4(6):712-5

Department of Materials Science & Engineering University of Washington 302L Roberts Hall Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/smll.200701103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692349PMC
June 2008

IL-21 mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytes.

Blood 2008 Jan 5;111(1):229-35. Epub 2007 Oct 5.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2007-05-08
Publisher Site
http://dx.doi.org/10.1182/blood-2007-05-089375DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200808PMC
January 2008

T-cell receptor tetramer binding or the lack there of does not necessitate antigen reactivity in T-cell receptor transduced T cells.

Cancer Immunol Immunother 2006 Sep 23;55(9):1142-50. Epub 2005 Dec 23.

Department of Surgery and Committee of Immunology, The University of Chicago, 5841 South Maryland Avenue, MC7116, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-005-0103-9DOI Listing
September 2006

Adoptive T-cell therapy of cancer.

Authors:
Cassian Yee

Hematol Oncol Clin North Am 2006 Jun;20(3):711-33

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2006.02.008DOI Listing
June 2006

IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response.

J Immunol 2005 Aug;175(4):2261-9

Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.175.4.2261DOI Listing
August 2005

Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells.

Proc Natl Acad Sci U S A 2005 May 11;102(18):6461-6. Epub 2005 Apr 11.

Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0501953102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1088382PMC
May 2005

Adoptive T cell therapy: Addressing challenges in cancer immunotherapy.

Authors:
Cassian Yee

J Transl Med 2005 Apr 28;3(1):17. Epub 2005 Apr 28.

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N,, D3-100, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://translational-medicine.biomedcentral.com/articles/10.
Publisher Site
http://dx.doi.org/10.1186/1479-5876-3-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1131930PMC
April 2005

Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.

Cancer Res 2005 Feb;65(4):1570-6

Department of Surgery and Medicine, University of Chicago, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-2076DOI Listing
February 2005

Autoreactive T cells in healthy individuals.

J Immunol 2004 May;172(10):5967-72

Benaroya Research Institute, Virginia Mason, Seattle, WA 98101, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.172.10.5967DOI Listing
May 2004

Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction.

Cancer Cell 2003 May;3(5):431-7

Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, Department of Medicine, Seattle, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1535-6108(03)00113-2DOI Listing
May 2003

Adoptive T cell therapy--immune monitoring and MHC multimers.

Authors:
Cassian Yee

Clin Immunol 2003 Jan;106(1):5-9

Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1521-6616(02)00015-3DOI Listing
January 2003

Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends.

J Clin Invest 2002 Nov;110(10):1415-7

Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, Department of Medicine, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI17214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC151827PMC
November 2002

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.

Nature 2002 Oct;419(6908):734-8

Fred Hutchinson Cancer Research Center, Clinical Research Division, 1100 Fairview Avenue North, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature01112DOI Listing
October 2002

Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses.

Nat Rev Cancer 2002 Jun;2(6):409-19

Clinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc820DOI Listing
June 2002